Portfolio Lab

Bausch Health Companies Inc.

  • Stock
  • Ticker BHC
  • ISIN CA0717341071
  • NYSE
  • US listing in dollars

Health care · Pharmaceuticals · Other countries

$8.22 −3.97%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Bausch Health Companies Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

BHCGlobal equities (VT)

$10,000 grew to $4,480. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −87.4% in 04/2025, measured from the peak in 03/2021. The old peak has not been reached again yet.

1-year return
+37.0%
5-year return p.a.
−20.6%
10-year return p.a.
−7.7%
Volatility p.a.
59.4%
Largest decline
−87.4%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue2,5592,2592,5302,6812,7962,5242,8522,941
Operating income558276444619474-950740983
EBITDA865581751925764-6551,0211,267
Net income93-58148179-112-1,423258436
Earnings per share0.25-0.160.400.48-0.30-3.820.681.15
Balance sheet
Total assets26,52326,42127,26626,82426,36624,49824,79425,484
Liabilities26,84526,66127,11926,46825,98925,58025,59625,825
Equity-1,279-1,183-764-565-554-2,059-1,771-1,328
Cash1,1811,1341,7271,3081,3091,2991,8252,485
Long-term debt18,94221,22820,85920,46320,59219,87519,87519,771
Cash flow
Operating cash flow601211289405495230670814
Capital expenditure-106-115-99-91-92-109-77-66
Free cash flow49596190314403121593748

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2019 at +62.0%, weakest 2022 at −77.3%. 5 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
29 Oct 2026$1.15
30 Jul 2026$0.68
30 Apr 2026−$3.82
19 Feb 2026−$0.30
30 Oct 2025$0.48
31 Jul 2025$0.40
1 May 2025−$0.16
20 Feb 2025$0.25
31 Oct 2024−$0.23
1 Aug 2024$0.03
2 May 2024−$0.17
22 Feb 2024−$0.10

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€2.8bn
Market cap in trading currency
$3.08bn
Enterprise value
$21.2bn
P/E
–
P/S
0.28
P/B
–
EV/Sales
1.91
EV/EBITDA
8.9
Earnings yield
–
FCF yield
60.6%

Results (last four quarters)

Revenue
$11.1bn
Gross profit
–
EBITDA
$2.40bn
Net income
−$841m
Earnings per share
−$2.29
Revenue per share
$29.69
Revenue growth
+9.7%
Earnings growth
+143.6%

Profitability

Gross margin
–
Operating margin
11.2%
Net margin
-7.6%
Return on equity
–
Return on assets
-3.3%

Balance sheet and cash flow

Cash
$2.49bn
Cash per share
$6.64
Financial debt
$20.6bn
Debt/equity %
–
Current ratio
1.56
Book value per share
−$3.55
Operating cash flow
$2.21bn
Free cash flow
$1.87bn

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
–
Ex-dividend date
–

Shares and trading

Shares outstanding
374m
Volume
3.75m
Avg. volume 3 months
3.10m
Relative volume
1.2

Price and technicals

Price
$8.22
1 day
−4.0%
52-week high
$8.91
52-week low
$4.43
Distance to 52-week high
−7.7%
Distance to 52-week low
+85.6%
Distance to 50-day line
+20.9%
Distance to 200-day line
+40.1%
RSI (14)
59
Volatility 1M
103.7%

Performance

1 week
−1.6%
1 month
+26.7%
3 months
+23.1%
6 months
+50.3%
YTD
+18.3%
1 year
+35.9%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has BHC performed since 11/2016?

$10,000 grew to $4,480 by 20 Nov 2026, which is −7.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is BHC?

Volatility was 59.4% per year, measured on monthly returns. The largest decline from a peak was −87.4%, with the low in 04/2025.

How does BHC compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, BHC returned −7.7% at 59.4%. The correlation of monthly returns was 0.25; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Why does this page show a US listing?

The figures use the stock's listing traded in the US. On individual days its path differs slightly from the price on the home exchange.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Bausch Health Companies Inc. (BHC): Return and risk